Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: Behavioral and histochemical effects

Brain Research Bulletin

Volumn 51, Issue 3, 2000, Pages 203-211

  Kaddis, F G ^a   Clarkson, E D ^a   Bell, K P ^a   Choi, P K ^a   Freed, C R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Conditioned medium; Differentiation; Dopamine; Muscle cells; Neurotransplantation; Parkinson's disease; Trophic factors; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUSPENSION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; MESENCEPHALON; MUSCLE CELL; MUSCLE FIBER CULTURE; NEWBORN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL TRANSPLANTATION; CELLS, CULTURED; CORPUS STRIATUM; CULTURE MEDIA, CONDITIONED; DENERVATION; FEMALE; FETAL TISSUE TRANSPLANTATION; HISTOCYTOCHEMISTRY; MALE; MESENCEPHALON; MUSCLE, SKELETAL; PARKINSON DISEASE; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 0033984913     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00216-6     Document Type: Article

References (57)

1. Bankiewicz K.S., Plunkett R.J., Mefford I., Kopin I.J., Oldfield E.H. Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites. Prog. Brain Res. 82:1990;561-571.
2. Bankiewicz K.S., Leff S.E., Nagy D., Jungles S., Rokovich J., Spratt K., Cohen L., Libonati M., Snyder R.O., Mandel R.J. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease. Exp. Neurol. 144:1997;147-156.
3. Bakay R.A., Fiandaca M.S., Barrow D.L., Schiff A., Collins D.C. Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates. Appl. Neurophysiol. 48:1985;358-361.
4. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
5. Bjorklund A., Dunnett S.B., Stenevi U., Lewis M.E., Iversen S.D. Reinnervation of the denervated striatum by substantia nigra transplants Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199:1980;307-333.
6. Cao L., Zheng Z.-C., Zhao Y.-C., Jiang Z.-H., Lie Z.-G., Chen S.-D., Zhou C.-F., Liu X.-Y. Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofection complex. Hum. Gene Ther. 6:1995;1497-1501.
7. Cotzias G.C., Van Woert M.H., Schiffer I.M. Aromatic amino acid and modification of parkinsonism. N. Engl. J. Med. 267:1967;374-379.
8. Dribin L.B., Barrett J.N. Conditioned medium enhances neuritic outgrowth from rat spinal cord explants. Dev. Biol. 74:1980;184-195.
9. Dunnett S.B., Hernandez T.D., Summerfield A., Jones G.H., Arbuthnott G. Graft-derived recovery from 6-OHDA lesion Specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71:1988;411-424.
10. During M.J., Naegele J.R., O'Malley K.L., Geller A. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
11. Ehringer H., Hornykiewicz O. Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin. Wochenschr. 38:1960;1236-1239.
12. Fisher L.J., Jinnah H.A., Kale L.C., Higgins G.A., Gage F.H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron. 6:1991;371-380.
13. Freed C.R., Richards J.B., Sabol K.E., Reite M.L. Fetal substantia nigra transplants lead to dopamine cell replacement and behavioral improvement in Bonnet monkeys with MPTP induced Parkinsonism. Beart P.M., Woodruff G., Jackson D.M. Pharmacology and functional regulation of dopaminergic neurons. 1988;353-361 Macmillan Press, London.
14. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Wells T.H., Barrett J.N., Grafton S.T., Huang S.C., Eidelberg D., Rottenberg D.A. Transplantation of human fetal dopamine cells for Parkinson's disease Results at one year. Arch. Neurol. 47:1990;505-512.
15. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J.-X., Lone T., Zhang Y.-B., Snyder J.A., Wells T.H., Ramig L.O., Thompson L., Mazziotta J.C., Huang S.C., Grafton S.T., Brooks D., Sawle G., Schroter G., Ansari A.A. Transplant survival and patient improvement six months to three years after fetal dopamine cell implants for Parkinson's disease. N. Engl. J. Med. 327:1992;1549-1555.
16. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.H. Bilateral fetal nigral transplantation into postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
17. Giller E.L. Jr, Neale J.H., Bullock P.N., Schrier B.K., Nelson P.G. Choline acetyltransferase activity of spinal cord cell culture increased by co-culture with muscle and by muscle conditioned medium. J. Cell Biol. 74:1977;16-29.
18. Henderson C.E., Huchet M., Changeux J.P. Neurite outgrowth from embryonic chicken spinal neurons is promoted by media conditioned by muscle cells. Proc. Natl. Acad. Sci. U.S.A. 78:1981;2625-2629.
19. Henderson C.C., Camu W., Mettling C., Gouin A., Poulsen K., Karihaloo M., Rullamas J., Evans T., McMahon S.B., Armanini M.P., Berkemeier L., Philips H., Rosenthal A. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature. 363:1993;266-270.
20. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simpson L.C., Moffet B., Vandlen R.A., Koliatsos V.E., Rosenthal A. GDNF A potent survival factor for motoneurons present in the peripheral nerve and muscle. Science. 266:1994;1062-1068.
21. Horellou P., Brundin P., Kalen P., Mallet J., Bjorklund A. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated striatum. Neuron. 5:1990;393-402.
22. Horellou P., Marlier L., Privat A., Mallet J. Behavioral effect of engineered cells that synthesize L-dopa or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2:1990;116-119.
23. Hyman C., Hofer M., Barde Y.-A, Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
24. Hyman C., Juhasz M., Jackson C., Wright P., Ip N., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
25. Iacovitti L. Effects of a novel differentiation factor on the development of catecholamine traits in noncatecholamine neurons from various regions of the rat brain Studies in tissue culture. J. Neurosci. 11:1991;2403-2409.
26. Iacovitti L., Evinger M.J., Joh T.H., Reis D.J. A muscle-derived factor(s) induced expression of a catecholamine phenotype in neurons of cultured rat cerebral cortex. J. Neurosci. 9:1989;3529-3537.
27. Iacovitti L., Evinger M.J., Stull N.D. Muscle derived differentiation factor increases expression of the tyrosine hydroxylase gene and enzyme activity in cultured dopamine neurons from the rat midbrain. Mol. Brain Res. 16:1992;215-222.
28. Jiao S., Wolff J.A. Long-term survival of autologous muscle grafts in rat brain. Neurosci. Lett. 137:1992;207-210.
29. Kaddis F.G., Clarkson E.D., Weber M.J., Vandenberg D.J., Donovan D.M., Mallet J., Horellou P., Uhl G.R., Freed C.R. Intrastriatal grafting of cos cells stably expressing human aromatic L-amino acid decarboxylase Neurochemical effects. J. Neurochem. 68:1997;1520-1526.
30. Kaddis F.G., Zawada W.M., Schaack J., Freed C.R. Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro. Cell Tissue Res. 286:1996;241-247.
31. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correlation using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154.
32. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J.G., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P., Olanow C.W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1995;1118-1124.
33. + toxicity. EMBO J. 14:1995;736-742.
34. Knusel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. U.S.A. 88:1991;961-965.
35. Li L.X., Wu W.T., Lin L.-F.H., Lei M., Oppenheim R.W., Houenou L.J. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9771-9775.
36. Lin L.-F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
37. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577.
38. Lindvall O., Sawle G., Widner H., Rothwell J.C., Björklund A., Brooks D., Brundin P., Frackowiak R., Marsden C.D., Odin P., Rechncrona S. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:1994;172-180.
39. McManaman J., Crawford F.G., Stewart S.S., Appel S.H. Purification of a skeletal muscle polypeptide which stimulates the choline acetyltransferase activity in cultured spinal cord neurons. J. Biol. Chem. 263:1988;5890-5897.
40. McManaman J., Crawford F., Clark R., Richker J., Fuller F. Multiple neurotrophic factors from skeletal muscle Demonstration of effects of basic fibroblast growth factor and comparison with the 22-kilodalton choline acetyltransferase development factor. J. Neurochem. 53:1989;1763-1771.
41. McManaman J.L., Haverkamp L.J., Oppenheim R.W. Skeletal muscle proteins rescue motor neurons from cell death in vivo. Adv. Neurol. 56:1991;81-88.
42. Oppenheim R.W., Yin Q.-W., Prevette D., Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature. 360:1992;755-757.
43. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.-F.H., Li L., Lo A.C., Newsome A.L., Prevette D.M., Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature. 373:1995;433-436.
44. Richards J.B., Sabol K.E., Freed C.R. Unilateral dopamine depletion causes bilateral deficits in the conditioned rotation in rats. Pharmacol. Biochem. Behav. 36:1990;217-223.
45. Schmidt R.H., Bjorklund A., Stenevi U., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspension. III. Activity of intrastriatal implants as assessed by dopamine synthesis and metabolism. Acta. Physiol. Scand. 522:(suppl.):1983;19-28.
46. 14C]2-deoxy-D-glucose autoradiography. J. Neurochem. 38:1982;737-748.
47. Sladek J.R. Jr, Collier T.J., Haber S.N., Roth R.H., Redmond D.E. Jr. Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res. Bull. 17:1986;809-818.
48. Smith R.G., Appel S.H. Extracts of skeletal muscle increase neurite outgrowth and cholinergic activity of fetal rat spinal motor neurons. Science. 219:1983;1079-1081.
49. Spencer D.D., Robbins R.J., Naftolin F., Marek K.L., Vollmer T., Leranth C., Roth R.H., Price L.H., Gjedde A., Bunney B.S., Sass K.J., Elsworth J.D., Kier E.L., Makuch R., Hoffer P.B., Redmond D.E. Jr. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327:1992;1541-1548.
50. Takayama H., Ray J., Raymon H., Baird A., Hogg J., Fisher L.J., Gage F.H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1:1995;53-58.
51. Trok K., Hoffer B., Olson L. Glial cell line-derived neurotrophic factor enhances survival and growth of prenatal and postnatal spinal cord transplants. Neuroscience. 71:1996;231-241.
52. Wakai S., Meiselman S.E., Brightman M.W. Focal circumvention of blood-brain barrier with grafts of muscle, skin and autonomic ganglia. Brain Res. 386:1986;209-222.
53. Widner H., Tetrud J., Rehncrona S., Snow B., Brundin P., Gustavii B., Bjorklund A., Lindvall O., Langston J.W. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1992;1556-1563.
54. Wolff J.A., Fisher L.J., Xu L., Jinnah H.A., Langlais P.J., Iuvone P.M., O'Malley K.L., Rosenberg M.B., Shimohama S., Friedmann T., Gage F.H. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9011-9014.
55. Yan Q., Elliott J., Snider W. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 360:1992;753-755.
56. Yan Q., Matheson C., Lopez O.T. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature. 373:1995;341-344.
57. Zurn A.D., Baetge E.E., Hammang J.P., Tan S.A., Aebischer P. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motor neurons. Neuroreport. 6:1994;113-118.